Moderna Inc. (NASDAQ:MRNA)

The valuation multiples reflect a period of extreme volatility and subsequent correction between 2019 and 2023, characterized by an initial surge in market valuation followed by a steady contraction in asset and sales multiples.

Price to Sales (P/S) Ratio

A dramatic peak is observed in 2020, with the ratio reaching 309.64. This was followed by a sharp decline to 3.45 in 2021 and a further dip to 2.92 in 2022. A reversal in this trend occurred in 2023, where the ratio increased to 5.52, indicating a shift in market valuation relative to revenue.

Price to Book Value (P/BV) Ratio

The ratio rose sharply from 8.21 in 2019 to a peak of 24.16 in 2020. From 2021 onward, a consistent downward trend is evident, with values falling to 4.31 in 2021, 2.81 in 2022, and 2.66 by the end of 2023, suggesting a significant reduction in the premium paid over the company's book value.

Price to Earnings (P/E) and Price to Operating Profit (P/OP) Ratios

These profitability-based multiples were only recorded for the years 2021 and 2022. Both ratios exhibited a moderate increase during this window; the P/E ratio rose from 5.00 to 6.43, and the P/OP ratio increased from 4.59 to 5.71. The absence of these figures in other years suggests periods of negative earnings or operating losses.

The financial data reveals a period of extreme volatility in both market valuation and bottom-line profitability. The company experienced a rapid transition from a loss-making entity to a highly profitable one, followed by a return to negative earnings, which heavily influenced the applicability and trajectory of the price-to-earnings multiples.

Share Price Trends

A significant appreciation in share price occurred between 2019 and 2020, with the value rising from 26.16 US$ to a peak of 154.81 US$. Following this surge, a gradual decline was observed through 2022, culminating in a more pronounced decrease to 96.46 US$ by the end of 2023.

Earnings Per Share (EPS) Performance

The EPS trajectory shows a sharp reversal in profitability. After recording losses in 2019 and 2020, EPS spiked to 30.29 US$ in 2021. This profitability diminished to 21.64 US$ in 2022 before returning to a negative value of -12.34 US$ in 2023.

Price-to-Earnings (P/E) Ratio Analysis

The P/E ratio was only calculable during the years of positive earnings. In 2021, the ratio stood at 5.00, increasing slightly to 6.43 in 2022. These relatively low multiples during a period of peak earnings suggest that the market may have viewed the surge in profitability as non-recurring or unsustainable. The ratio is absent for 2019, 2020, and 2023, corresponding with the periods of negative EPS.

The financial trajectory between 2019 and 2023 is characterized by extreme volatility in both market valuation and operational profitability. A period of significant growth and profitability was concentrated between 2021 and 2022, preceded and succeeded by operational losses.

Share Price Dynamics

A sharp escalation in share price is observed from 26.16 US$ in 2019 to a peak of 154.81 US$ in 2020. Following this peak, a consistent downward trend emerged, with the price declining to 139.26 US$ in 2022 and further retreating to 96.46 US$ by December 31, 2023.

Operating Profitability Trends

Operational performance transitioned from losses of -1.48 US$ and -1.91 US$ per share in 2019 and 2020, respectively, to a substantial surge in 2021, where operating profit per share reached 33.00 US$. Profitability remained positive but declined to 24.38 US$ in 2022, before reverting to an operating loss of -11.09 US$ per share in 2023.

Price to Operating Profit (P/OP) Analysis

The P/OP ratio was only applicable during the profitable window of 2021 and 2022. The ratio rose from 4.59 in 2021 to 5.71 in 2022. This increase in the multiple, occurring alongside a decrease in operating profit per share, indicates that the market valuation remained disproportionately high relative to the declining operational earnings during that period. The ratio became non-calculable in 2023 due to the return to negative operating results.

The valuation trajectory from 2019 to 2023 reflects a volatile transition from speculative pricing to revenue-driven valuation, followed by a period of contraction. The relationship between share price and sales per share indicates a dramatic shift in market expectations and realized financial performance over the five-year period.

Share Price Trends

A significant escalation in share price occurred between 2019 and 2020, rising from 26.16 to 154.81. This peak was maintained with relative stability through 2022 before a notable decline to 96.46 by the end of 2023, representing a correction from the period's highest valuations.

Sales per Share Performance

Revenue realization shifted abruptly in 2021, with sales per share jumping from 0.50 in 2020 to 43.87. Performance peaked in 2022 at 47.72 before experiencing a sharp contraction in 2023, falling to 17.46. This indicates a substantial reduction in the revenue generated per outstanding share in the final year of the analysis.

Price-to-Sales (P/S) Ratio Analysis

The P/S ratio exhibited extreme variance, starting at an outlier high of 309.64 in 2020, which suggests a valuation based almost entirely on future expectations rather than current revenue. This ratio normalized rapidly as sales materialized, reaching a low of 2.92 in 2022. However, by 2023, the P/S ratio rose to 5.52; this increase occurred because the decline in sales per share was more severe than the decline in the share price, resulting in a higher multiple relative to the diminished revenue base.

The valuation metrics from 2019 to 2023 indicate a period of significant volatility characterized by an initial surge in market valuation followed by a sustained compression of the price-to-book multiple. The divergence between share price movements and book value growth highlights a transition from a high-growth speculative premium to a more conservative valuation basis.

Price to Book Value (P/BV) Ratio

A dramatic increase is observed between 2019 and 2020, with the P/BV ratio rising from 8.21 to a peak of 24.16. This was followed by a sharp contraction in 2021 to 4.31, and a further steady decline to 2.66 by December 31, 2023. This trajectory suggests that the market's willingness to pay a premium over the book value peaked in 2020 and has since significantly moderated.

Book Value Per Share (BVPS)

The BVPS exhibited a strong upward trend for the majority of the period, increasing from 3.19 US$ in 2019 to a peak of 49.50 US$ in 2022. This represents a substantial expansion of the company's net asset value per share. However, a decline occurred in 2023, with the BVPS falling to 36.26 US$, indicating a reduction in equity value during the final year of the observed period.

Share Price Dynamics

The share price experienced an abrupt increase from 26.16 US$ in 2019 to 154.81 US$ in 2020. Following this peak, a gradual downward trend was established, with the price ending at 96.46 US$ in 2023. The misalignment between the timing of the share price peak (2020) and the BVPS peak (2022) accounts for the rapid compression of the P/BV ratio throughout 2021 and 2022.